MedPage Today on MSN
Liver cancer treatment landscape shifts rapidly, but best sequencing still unclear
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma ...
Misconceptions about HCC often lead to stigma, but early detection can significantly improve treatment outcomes and survival ...
Liver cancer remains one of the deadliest cancers worldwide, something that escapes early detection. Understand liver cancer, ...
MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...
Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths worldwide, is extremely challenging to treat. However, the future of HCC ...
Recurrence beyond Milan criteria predicts worse outcomes after hepatocellular carcinoma resection. Limited recurrence remains manageable.
This Research Topic is part of the series of "Hepatocellular Carcinoma: Novel Treatment Strategies":Hepatocellular Carcinoma: Novel Treatment Strategies - ...
People coinfected with HIV and hepatitis C virus remain at risk for hepatocellular carcinoma within 6 years of starting ...
Clinicians in 5 states participated in an online survey to gauge the level of compliance with HCC surveillance guidelines. According to the survey, knowledge gaps and barriers to HCC screening in ...
Early detection of hepatocellular carcinoma (HCC) is crucial for improving patient outcomes and offers the best chance for curative treatment, making HCC screening a vital strategy for high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results